Lakewood-Amedex Biotherapeutics
Lakewood Amedex Inc., a biotech company, specializes in developing anti-infective therapeutics.
Founded
2006Lakewood Amedex Inc., a biotech company, specializes in developing anti-infective therapeutics.
Lakewood Amedex Inc., founded with a mission to address the critical need for novel antimicrobial therapeutics, focuses on developing anti-infective drugs. The company's core vision is to revolutionize the treatment of infectious diseases through innovative therapeutics, specifically their proprietary BisphosphocinsTM. These products aim to reduce hospital stays and avoid lengthy treatments associated with conventional antibiotics, targeting a significant market need in the healthcare industry.
The leadership team at Lakewood Amedex boasts over 100 years of combined experience in the pharmaceutical sector, ensuring a robust pathway from development to market. Notable achievements include the advancement of their BisphosphocinsTM, which hold the potential to significantly impact patient care and healthcare costs. The company’s efforts have positioned it as a key player in the biotechnology space, contributing to the global fight against infectious diseases.
Companies similar to Lakewood-Amedex Biotherapeutics include Innovative Biologics, Actinobac Biomed, X-Biotix Therapeutics and ExoLytics.
Lakewood-Amedex Biotherapeutics was founded in 2006.
Lakewood-Amedex Biotherapeutics' headquarters is located in Sarasota, FL, US.
Lakewood-Amedex Biotherapeutics' most recent funding round was for $24.1M (USD) in January 2021.
As of Jan 22, 2021, Lakewood-Amedex Biotherapeutics has raised a total of $29.6M (USD).
Lakewood-Amedex Biotherapeutics has 40 employees as of Feb 5, 2024.
X-Biotix Therapeutics
